baseballnewssource
Senator Tommy Tuberville (Republican-Alabama) recently sold shares of Pfizer Inc.
(NYSE:PFE).
In a filing disclosed on July 16th, the Senator disclosed that they had sold between $15,001 and $50,000 in Pfizer stock on June 8th.
Senator Tommy Tuberville also recently made the following trade(s): - Sold $1,001 $15,000 in shares of Wabtec (NYSE:WAB) on 6/9/2026.
- Sold $15,001 $50,000 in shares of American Water Works (NYSE:AWK) on 6/8/2026.
- Sold $15,001 $50,000 in shares of CSX (NASDAQ:CSX) on 6/8/2026.
- Sold $15,001 $50,000 in shares of Duke Energy (NYSE:DUK) on 6/8/2026.
- Sold $15,001 $50,000 in shares of Lockheed Martin (NYSE:LMT) on 6/8/2026.
- Sold $15,001 $50,000 in shares of Mastercard (NYSE:MA) on 6/8/2026.
- Sold $15,001 $50,000 in shares of NextEra Energy (NYSE:NEE) on 6/8/2026.
- Sold $15,001 $50,000 in shares of Procter & Gamble (NYSE:PG) on 6/8/2026.
- Sold $1,001 $15,000 in shares of Tractor Supply (NASDAQ:TSCO) on 6/8/2026.
Pfizer Trading Down 0.2% Shares of NYSE PFE traded down $0.06 during trading hours on Friday, hitting $25.08.
45,600,737 shares of the company traded hands, compared to its average volume of 45,182,364.
The companys 50 day moving average price is $25.21 and its 200 day moving average price is $26.17.
Pfizer Inc.
has a 12 month low of $23.11 and a 12 month high of $28.75.
The stock has a market capitalization of $142.94 billion, a price-to-earnings ratio of 19.15 and a beta of 0.35.
The company has a current ratio of 1.25, a quick ratio of 0.94 and a debt-to-equity ratio of 0.67.
Pfizer Announces Dividend The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 1st.
Stockholders of record on Friday, July 24th will be issued a $0.43 dividend.
The ex-dividend date is Friday, July 24th.
This represents a $1.72 dividend on an annualized basis and a dividend yield of 6.9%.
Pfizers payout ratio is 131.30%.
Hedge Funds Weigh In On Pfizer Several institutional investors have recently made changes to their positions in PFE.
Evolution Wealth Management Inc.
increased its holdings in shares of Pfizer by 132.2% during the first quarter.
Evolution Wealth Management Inc.
now owns 994 shares of the biopharmaceutical companys stock valued at $28,000 after acquiring an additional 566 shares in the last quarter.
Horizon Financial Services LLC grew its position in Pfizer by 174.8% during the 4th quarter.
Horizon Financial Services LLC now owns 1,014 shares of the biopharmaceutical companys stock worth $25,000 after purchasing an additional 645 shares during the last quarter.
Godfrey Financial Associates Inc.
acquired a new position in Pfizer during the 4th quarter valued at approximately $26,000.
Keb Asset Management LLC purchased a new position in shares of Pfizer in the second quarter worth $26,000.
Finally, YANKCOM Partnership purchased a new position in shares of Pfizer in the fourth quarter worth $28,000.
Hedge funds and other institutional investors own 68.36% of the companys stock.
Analysts Set New Price Targets Several equities research analysts have recently weighed in on the company.
Citigroup increased their price target on Pfizer from $26.00 to $27.00 and gave the stock a neutral rating in a report on Wednesday, April 29th.
Wall Street Zen lowered Pfizer from a buy rating to a hold rating in a research note on Saturday, July 4th.
Morgan Stanley boosted their target price on shares of Pfizer from $27.00 to $28.00 and gave the company an equal weight rating in a research note on Friday, April 10th.
HSBC cut shares of Pfizer from a buy rating to a hold rating and cut their price target for the stock from $32.00 to $28.00 in a report on Monday, July 6th.
Finally, Bank of America decreased their price objective on shares of Pfizer from $27.00 to $26.00 and set a neutral rating for the company in a report on Friday, July 10th.
One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, fourteen have given a Hold rating and two have assigned a Sell rating to the stock.
According to MarketBeat, the company presently has an average rating of Hold and an average target price of $28.50.
Key Stories Impacting Pfizer Here are the key news stories impacting Pfizer this week: - Positive Sentiment: Recent commentary continues to focus on Pfizers pipeline potential, with articles asking whether the company can strengthen its growth story through new drug development and recent approvals, which could support a longer-term rebound.
Can Pfizer (NYSE:PFE) Strengthen Its Pipeline Story? - Positive Sentiment: Pfizer remains attractive to income-focused investors, with coverage highlighting it as a high-yield dividend stock and a potential buy on the dip name, which may help limit downside.
3 High-Yield Dividend Stocks to Buy and Hold - Neutral Sentiment: Analysts are still modeling solid full-year earnings, but Erste Group slightly trimmed its FY2026 EPS estimate for Pfizer to $2.92 from $2.95, signaling only a small downward revision versus the consensus of $2.96.
- Neutral Sentiment: Another valuation-focused note said Pfizer looks fairly priced given mixed pipeline risks, suggesting the stock may not be obviously cheap despite its lower valuation and high dividend.
- Negative Sentiment: Pfizer suspended sales of Premarin vaginal cream in India because of supply challenges, adding another operational headwind for the company.
Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges - Negative Sentiment: Arbutus Biopharma filed international patent lawsuits against Pfizer and BioNTech over lipid nanoparticle technology used in mRNA vaccines, keeping legal risk and potential costs in focus for PFE.
Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech..
About Senator Tuberville Tommy Tuberville (Republican Party) (also known as Coach) is a member of the U.S.
Senate from Alabama.
He assumed office on January 3, 2021.
His current term ends on January 3, 2027.
Tuberville (Republican Party) ran for election to the U.S.
Senate to represent Alabama.
He won in the general election on November 3, 2020.
Tuberville was head coach for several college football teams between 1995 and 2016, including at Auburn University and the University of Cincinnati.
Tommy Tuberville was born in Camden, Arkansas, and lives in Auburn, Alabama.
Tubervilles career experience includes working as a studio analyst with ESPN and as the head football coach of the University of Mississippi, the University of Auburn, Texas Tech University, and the University of Cincinnati.
Pfizer Company Profile Pfizer Inc (NYSE: PFE) is a multinational biopharmaceutical company headquartered in New York City.
Founded in 1849 by Charles Pfizer and Charles Erhart, the company researches, develops, manufactures and commercializes a broad range of medicines and vaccines for human health.
Its activities span discovery research, clinical development, regulatory affairs, manufacturing and global commercial distribution across multiple therapeutic areas.
Pfizers portfolio and pipeline cover oncology, immunology, cardiology, endocrinology, rare diseases, hospital acute care and anti-infectives, along with a substantial vaccine business.
See Also - Five stocks we like better than Pfizer - Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop - Delta vs.
United: Which Airline Is Better Built for Higher Fuel Costs? - The Market Sold Alcoa After EarningsBut It May Be Missing the Real Story - Why Intuitive Surgicals Strong Quarter Still Spooked Investors Receive News & Ratings for Pfizer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pfizer and related companies with MarketBeat.com's FREE daily email newsletter.